What is the dosing for Levofloxacin (Levofloxacin) for various infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levofloxacin Dosing for Various Infections

Levofloxacin dosing varies by infection type and severity, with standard adult doses ranging from 250 mg to 750 mg once daily, administered orally or intravenously for durations of 3 to 14 days depending on the clinical indication. 1

Standard Adult Dosing by Infection Type

Respiratory Tract Infections

Community-Acquired Pneumonia (CAP):

  • Standard regimen: 500 mg once daily for 7-14 days 2, 1
  • High-dose short-course: 750 mg once daily for 5 days is equally effective and FDA-approved 3, 4
  • For severe CAP requiring ICU care, consider 750 mg IV once daily or 500 mg IV twice daily, often combined with other antibiotics 3

Acute Bacterial Sinusitis:

  • 750 mg once daily for 5 days 3, 1
  • Alternative: 500 mg once daily for 10-14 days 5

Acute Exacerbations of Chronic Bronchitis:

  • 500 mg once daily for 7 days 3, 1

Nosocomial Pneumonia:

  • 750 mg IV once daily for 7-14 days, with option to switch to oral when clinically appropriate 2, 5

Urinary Tract Infections

Uncomplicated UTIs:

  • 250 mg once daily for 3 days 1, 6

Complicated UTIs and Acute Pyelonephritis:

  • Standard: 250 mg once daily for 7-10 days 1, 6
  • High-dose short-course: 750 mg once daily for 5 days 4, 1
  • Use only where fluoroquinolone resistance in community uropathogens does not exceed 10% 2

Chronic Bacterial Prostatitis:

  • 500 mg once daily for 28 days 5

Skin and Soft Tissue Infections

Uncomplicated Skin Infections:

  • 500 mg once daily for 7-10 days 1, 5

Complicated Skin and Skin Structure Infections:

  • 750 mg IV/oral once daily for 7-14 days 2, 1

Drug-Resistant Tuberculosis

When first-line agents cannot be used:

  • 500-1,000 mg daily for adults 7, 2
  • Levofloxacin is the preferred fluoroquinolone for MDR-TB due to established long-term safety profile 7
  • Should not be used as first-line agent for drug-susceptible TB 7

Pediatric Dosing

General principle: Levofloxacin is generally not recommended for routine pediatric use due to concerns about effects on bone and cartilage growth 7

When benefits outweigh risks (e.g., MDR-TB, resistant infections):

  • Children ≥5 years: 10 mg/kg once daily (maximum 750 mg) 7, 2
  • Children 6 months to <5 years: 10 mg/kg divided every 12 hours (maximum 750 mg/day) due to faster drug clearance 7, 2

Specific indications where fluoroquinolones may be considered: 7

  • Complicated UTIs with resistant organisms
  • Acute otitis media or sinusitis when other options have failed
  • Pneumonia caused by resistant S. pneumoniae
  • Tuberculosis resistant to isoniazid and rifampin 3

Renal Dose Adjustments

Critical consideration: Levofloxacin is 80% renally cleared and requires dose adjustment for creatinine clearance <50 mL/min 7, 1

Dosing adjustments: 1

  • CrCl 20-49 mL/min:
    • For 750 mg dose: Give 750 mg initial dose, then 750 mg every 48 hours
    • For 500 mg dose: Give 500 mg initial dose, then 250 mg every 24 hours
  • CrCl 10-19 mL/min:
    • For 750 mg dose: Give 750 mg initial dose, then 500 mg every 48 hours
    • For 500 mg dose: Give 500 mg initial dose, then 250 mg every 48 hours
  • Hemodialysis: No supplemental doses needed after dialysis 7

Administration Considerations

Drug interactions requiring timing adjustments:

  • Administer at least 2 hours before or 2 hours after antacids containing magnesium or aluminum, sucralfate, iron, multivitamins with zinc, or didanosine 1, 7

Food and hydration:

  • Can be administered without regard to food 1
  • Maintain adequate hydration to prevent crystalluria 1

IV to oral transition:

  • Oral formulation is bioequivalent to IV; seamless transition is possible 4, 8

Special Population Warnings

Pregnancy:

  • Avoid use due to teratogenic effects 7, 2

Hepatic disease:

  • No dose adjustment required; presumed safe but use with caution 7

Important Clinical Caveats

Resistance considerations:

  • Previous fluoroquinolone exposure may preclude use due to resistance 3
  • Current S. pneumoniae resistance to levofloxacin remains <1% in the US 5
  • For Pseudomonas aeruginosa infections, combine with antipseudomonal beta-lactams 3, 8

Monitoring:

  • Monitor clinical response using temperature, respiratory parameters, and hemodynamic stability 3
  • Treatment should generally not exceed 8 days in responding patients 3

References

Guideline

Levofloxacin Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Levofloxacin Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Role of levofloxacin in the treatment of urinary tract infections].

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Levofloxacin in the treatment of community-acquired pneumonia.

Expert review of anti-infective therapy, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.